Cargando…

Intravesical VAX014 Synergizes with PD-L1 Blockade to Enhance Local and Systemic Control of Bladder Cancer

Emerging clinical evidence indicates that the combination of local administration of immunotherapy with systemic immune-checkpoint blockade targeting the PD-1/PD-L1 pathway improves response rates in select solid tumor indications; however, limited clinical experience with this approach exists in ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsuji, Shingo, Reil, Katherine, Nelson, Kinsey, Proclivo, Veronica H., McGuire, Kathleen L., Giacalone, Matthew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357178/ https://www.ncbi.nlm.nih.gov/pubmed/35679299 http://dx.doi.org/10.1158/2326-6066.CIR-21-0879

Ejemplares similares

Intralesional administration of VAX014 facilitates in situ immunization and potentiates immune checkpoint blockade in immunologically cold tumors
por: Reil, Katherine A, et al.
Publicado: (2023)

VAX014, an Oncolytic Therapy, Reduces Adenomas and Modifies Colon Microenvironment in Mouse Model of CRC
por: Grenier, Shea F., et al.
Publicado: (2023)

Preclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer
por: Tsuji, Shingo, et al.
Publicado: (2016)

Intravesical chemotherapy synergize with an immune adjuvant by a thermo-sensitive hydrogel system for bladder cancer
por: Liu, J., et al.
Publicado: (2023)

Magnetic Field Effects on the Structure, Dielectric and Energy Storage Properties of High-Entropy Spinel Ferrite (La(0.14)Ce(0.14)Mn(0.14)Zr(0.14)Cu(0.14)Ca(0.14)Ni(0.14))Fe(2)O(4)/PVDF Nanocomposites
por: Qiao, Jiale, et al.
Publicado: (2023)

SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
por: Zhao, Mingxia, et al.
Publicado: (2019)

PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer
por: Liu, Peng, et al.
Publicado: (2022)

Blockade of Acid-Sensing Ion Channels Increases Urinary Bladder Capacity With or Without Intravesical Irritation in Mice
por: Yoshiyama, Mitsuharu, et al.
Publicado: (2020)

HealVax
por: Foerster, John, et al.
Publicado: (2018)

Corrigendum: Blockade of Acid-Sensing Ion Channels Increases Urinary Bladder Capacity With or Without Intravesical Irritation in Mice
por: Yoshiyama, Mitsuharu, et al.
Publicado: (2020)

PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells
por: Viramontes, Karla M., et al.
Publicado: (2022)

P014. Migraine and hypnosis
por: Ardore, Marco, et al.
Publicado: (2015)

To vax or not to vax: Predictors of anti-vax attitudes and COVID-19 vaccine hesitancy prior to widespread vaccine availability
por: Roberts, Hannah A., et al.
Publicado: (2022)

Intravesical Treatments of Bladder Cancer: Review
por: Shen, Zancong, et al.
Publicado: (2008)

Intravesical therapy for urothelial carcinoma of the bladder
por: Manoharan, M.
Publicado: (2011)

Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade
por: Ocadlikova, Darina, et al.
Publicado: (2021)

BET inhibitor JQ1 enhances anti-tumor immunity and synergizes with PD-1 blockade in CRC
por: Wang, Huijin, et al.
Publicado: (2022)

Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens
por: Karnasuta, Chitraporn, et al.
Publicado: (2017)

VAX Software Overview
por: DELPHI Collaboration
Publicado: (1982)

Central VAX upgrade
Publicado: (1987)

VAX support installation
por: Luque, Maria
Publicado: (2021)

Hyperthermia as Adjunct to Intravesical Chemotherapy for Bladder Cancer
por: Owusu, Richmond A., et al.
Publicado: (2013)

Intravesical immunotherapy in nonmuscle invasive bladder cancer
por: Jokisch, Jan-Friedrich, et al.
Publicado: (2015)

The use of intravesical BCG in urothelial carcinoma of the bladder
por: Alhunaidi, Omar, et al.
Publicado: (2019)

Intravesical Agents in the Treatment of Bladder Clots in Children
por: Della Corte, Marcello, et al.
Publicado: (2023)

A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control
por: Tondini, Elena, et al.
Publicado: (2019)

Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis
por: Guan, Xin, et al.
Publicado: (2022)

Title unknown, CERN-ALEPH-2001-014
por: CERN. Geneva. ALEPH
Publicado: (2001)

P01-014 – Subclinical atherosclerosis in FMF
por: Ugurlu, S, et al.
Publicado: (2013)

LBODP014 Hyperaldosteronism Caused By Adrenal Cyst
por: Vargas, Laura Valentina Estupiñan, et al.
Publicado: (2022)

Evaluation of a ConvitVax/anti-PD-1 combined immunotherapy for breast cancer treatment
por: Godoy-Calderón, María José, et al.
Publicado: (2019)

Correlation of Male Overactive Bladder with Intravesical Prostatic Protrusion
por: Kim, Ki Hong, et al.
Publicado: (2010)

Disseminated BCG: Complications of Intravesical Bladder Cancer Treatment
por: To, Uyen, et al.
Publicado: (2014)

Intravesical chemotherapy in non-muscle-invasive bladder cancer
por: Porten, Sima P., et al.
Publicado: (2015)

Intravesical therapy for bladder cancer in the pandemic of Covid-19
por: Teoh, Jeremy Y. C., et al.
Publicado: (2020)

Model of the VAX-11/780
Publicado: (1977)

New VAX computer arrives
Publicado: (1985)

VAX architecture reference manual /
Publicado: (1987)

ADAMO installation on a VAX
por: Fisher, S M
Publicado: (1986)

VAX Cluster User's Guide
por: Bunn, Julian, et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_tnj21ekslfpg19ag2tllcdf3bp